We are live on ! Find out more
SNOA icon

Sonoma Pharmaceuticals
SNOA

14 hedge funds and large institutions have $1.88M invested in Sonoma Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

26% more capital invested

Capital invested by funds: $1.49M → $1.88M (+$388K)

18% less funds holding

Funds holding: 17 → 14 (-3)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
14
Holders Change
-3
Holders Change %
-17.65%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BA
Bard Associates
Illinois
+$434K
2
BRWA
B. Riley Wealth Advisors
Florida
+$43.8K
3
Bank of America
Bank of America
North Carolina
+$12.2K
4
U
UBS
Switzerland
+$4.87K

Top Sellers

Rank Fund Capital Flow
1
BIM
Bogle Investment Management
Massachusetts
-$112K
2
Morgan Stanley
Morgan Stanley
New York
-$31.7K
3
RCM
Rotella Capital Management
Washington
-$28K
4
TRCT
Tower Research Capital (TRC)
New York
-$20K
5
OWP
Obermeyer Wealth Partners
Colorado
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
1
Bard Associates
Illinois
$623K +$434K +178 +237%
BIT
2
BlackRock Institutional Trust
California
$330K – – –
Morgan Stanley
3
Morgan Stanley
New York
$322K -$31.7K -13 -9%
Vanguard Group
4
Vanguard Group
Pennsylvania
$318K – – –
BRWA
5
B. Riley Wealth Advisors
Florida
$162K +$43.8K +18 +38%
BIM
6
Bogle Investment Management
Massachusetts
$50K -$112K -46 -69%
California Public Employees Retirement System
7
California Public Employees Retirement System
California
$25K – – –
Bank of Montreal
8
Bank of Montreal
Ontario, Canada
$12K – – –
Bank of America
9
Bank of America
North Carolina
$12K +$12.2K +5 New
U
10
UBS
Switzerland
$10K +$4.87K +2 +100%
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
$9K – – –
Wells Fargo
12
Wells Fargo
California
$4K – – –
LTFS
13
Ladenburg Thalmann Financial Services
Florida
$2K – – –
CCM
14
Chilton Capital Management
Texas
$1.38K – – –
RCM
15
Rotella Capital Management
Washington
– -$28K -12 Closed
TRCT
16
Tower Research Capital (TRC)
New York
– -$20K -8 Closed
OWP
17
Obermeyer Wealth Partners
Colorado
– -$4K -2 Closed
PFO
18
Pathstone Family Office
New Jersey
– -$2K -1 Closed

SNOA Hedge Fund Activity: Q3 2013 in Review

14 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q3 2013, worth a combined $1.88M — up 26% from $1.49M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of SNOA and 1 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 3 added.

The largest buyer was Bard Associates, adding an estimated $434K. The largest seller was Bogle Investment Management, cutting an estimated $112K.

  • 14 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q3 2013, down from 17 in Q2 2013.
  • Funds reported $1.88M of Sonoma Pharmaceuticals stock for Q3 2013, up 26% quarter-over-quarter.
  • 1 fund opened new Sonoma Pharmaceuticals positions in Q3 2013 and 4 closed out, a net change of -3 holders.
  • The largest Sonoma Pharmaceuticals buyer in Q3 2013 was Bard Associates, an estimated $434K added.
  • The largest Sonoma Pharmaceuticals seller in Q3 2013 was Bogle Investment Management, an estimated $112K sold.

Based on aggregated 13F filings for Q3 2013.